Mifepristone Promotes Adiponectin Production and Improves Insulin Sensitivity in a Mouse Model of Diet-Induced-Obesity
Open Access
- 6 November 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11) , e79724
Abstract
The steroid receptor antagonist mifepristone is used as an anti-cancer agent, eliciting both cytostatic and cytotoxic effects on malignant cells. However, the metabolic effects of long-term treatment with mifepristone have remained unclear. The effects of mifepristone on insulin sensitivity and adiponectin secretion were evaluated both in in vivo and in vitro. First, we explored the effects of mifepristone, on metabolic functions in obese mice receiving a high-fat diet. When these mice were fed mifepristone, they exhibited a marked improvement in insulin sensitivity, attenuated hepatic injury, and decreased adipocyte size, compared with mice that received only the high-fat diet. Intriguingly, mifepristone-treated mice showed significantly elevated plasma adiponectin levels. Second, we tested the effects of mifepristone on differentiated 3T3-L1 adipocytes in vitro. When differentiated adipocytes were treated with mifepristone for 48 h, adiponectin was upregulated at both mRNA and protein levels. Collectively, these results reveal novel actions of mifepristone on metabolic functions, in vivo and in vitro, in which the drug exerts antidiabetic effects associated with an upregulation in adiponectin-secretion.Keywords
This publication has 50 references indexed in Scilit:
- Revealing a steroid receptor ligand as a unique PPARγ agonistCell Research, 2011
- Pioglitazone promotes preadipocyte proliferation by downregulating p16Ink4aBiochemical and Biophysical Research Communications, 2011
- Inflammatory links between obesity and metabolic diseaseJournal of Clinical Investigation, 2011
- Dynamics of insulin secretion and the clinical implications for obesity and diabetesJournal of Clinical Investigation, 2011
- Sphingosine kinase is induced in mouse 3T3-L1 cells and promotes adipogenesisJournal of Lipid Research, 2009
- Adiponectin translation is increased by the PPARγ agonists pioglitazone and ω-3 fatty acidsAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- RU486 did not exacerbate cytokine release in mice challenged with LPS nor in db/db miceBMC Pharmacology, 2008
- Aldosterone Suppresses Insulin Signaling Via the Downregulation of Insulin Receptor Substrate-1 in Vascular Smooth Muscle CellsHypertension, 2007
- Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-γ activationBiochemical and Biophysical Research Communications, 2007
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003